dont know why NPRA process takes so long.

Pls. send us the news once it is out, ok, CKNG8291

What went up, will go down. What went down, will go up. hehehe

A great day for Cansino today.

lama sangat, akar pun berkulat nanti

Very very boring...very low volume.

wow..you are right. It did rebound before 4pm just now.

CanSino Bio Says No Blood Clot Found in 1m Covid Vaccinations
Bloomberg First Word
By Natalie Lung
14 April 2021

The vector of the recombinant novel coronavirus vaccine that CanSino Biologics has developed is Adenovirus Type 5 vector, and is different from the ChAdOx1 and Adenovirus Type 26 vectors of the AstraZeneca vaccine and J&J vaccine respectively, according to Hong Kong stock exchange filing.
• No blood clot related serious adverse events have been reported in around 1m people who received the Ad5-nCoV vaccine, company says.

Will fly soon, like supermax today

https://www.theedgemarkets.com/article/malaysia-receive-35-million-doses-cansino-covid19-vaccine-stages-month-says-adham

Yes...the share will fly as what panguin wishes. Government will buy more Cansino vaccine as other suppliers are having supply constraint and some issue.

I also need to eat mcflurry to cool me down...Warren Buffet once said "The stock market is a device for transferring money from the impatient to the patient."

loosing steam....getting lower each day...need a jab.

hibernation period..waiting to explode big time.

https://www.thestar.com.my/aseanplus/aseanplus-news/2021/02/28/china039s-first-1-dose-covid-19-vaccine-rolls-out-500m-people-can-be-inoculated-a-year?fbclid=IwAR2oXx7_AMX28QPsnFMiUOzuVWvkadMRIsiuNho26MrqlEUggS2M3O45Xag

KOTA KINABALU:
CanSinoBio would be SAPP Presedent (pic) fist choice of vaccines when his turn comes for vaccination.
"This is because taking the CansinoBio vaccine involves taking only nine steps as only one dose of the vaccine is needed," he said in a statement, Friday.
"After one dose, a recipient of this vaccine will be given a vaccine card, also nicknamed vaccine passport."
"For all the other four types of vaccines, two doses involving a total of 18 steps are needed before the vaccine is deemed to be effective and a vaccine card is given."
He said based on the official publication of the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV), the procedure after taking each dose is to monitor for AEFI (After Effects Following Immunization).

(Reuters) - China's medical products regulator said on Thursday that it had approved two more COVID-19 vaccines for public use, raising the number of domestically produced vaccines that can be used in China to four.

The two newly cleared vaccines are made by CanSino Biologics Inc (CanSinoBIO) and Wuhan Institute of Biological Products, an affiliate of China National Pharmaceutical Group (Sinopharm).
(Reuters) - China's medical products regulator said on Thursday that it had approved two more COVID-19 vaccines for public use, raising the number of domestically produced vaccines that can be used in China to four.

https://mobile.reuters.com/article/amp/idUSKBN2AP1MW

https://www.linkedin.com/posts/jaypadasian_cansino-biologics-steps-into-the-spotlight-activity-6768054039906279425-GMae
Interim analyses have shown that CanSino’s vaccine is well tolerated across age groups, with no reports of serious adverse events. Outside of the trials, more than 150,000 members of the Chinese military have already received the vaccine under an emergency use agreement. Experts have touted the desirability of a single-dose vaccine at a time when manufacturing capacity is scarce and infection rates are soaring.
In addition to short-term efficacy data, CanSino’s results will ultimately provide the first measures of the durability of the protection conferred by a COVID-19 vaccine. The trial, which spans 70 sites and 40,000 participants in Argentina, Chile, Mexico, Pakistan, and Russia, includes a cohort of participants who are being tracked for a full year following vaccination. To date, CanSino is the only vaccine developer with a trial spanning that length of time. Those results are expected in the Fall.
CanSino is also testing a two-dose regimen in China, a trial that is likely to be among the first in the world to provide safety and efficacy data on a COVID-19 vaccine in young children. The two-dose trial, which began in September, includes participants as young as six years old.

CanSino vaccine 65.7% effective against symptomatic coronavirus cases, 90.98% against severe disease

https://www.globaltimes.cn/page/202102/1215342.shtml

at current trend no appetite to eat....sleepy.

Hope for good Solution days, this week.

UlarSawa...if you dont like Cansino, pls. stop commenting.

From today Star newspaper.
"In addition, the government is in final negotiations with
CanSino to secure a vaccine supply increase to cover
more than 80% or 26.5 million of the country's total
population by the first quarter of next year."

trending up this morning...pls. continue to go up and up

We just need to wait for the Cansino Phase 3 trial results which will come up soon, I guess. Hope will be better than Sinovac results.

How does this companybrelated to Covid 19nor vaccine?

what is IMBC, prince11?

Is Medical Biology Chinese Academy of Medical Sciences in Beijing producing cansino vaccine (Solutn company)?

https://malaysia.yahoo.com/news/dr-noor-hisham-malaysia-start-115144228.html

up and down...hope will go up again

https://www.thestar.com.my/news/nation/2020/10/24/covid-19-vaccine-expected-to-be-secured-in-first-quarter-next-year-priority-to-be-given-to-frontliners

75sen resistance is very strong..let see tomorrow

huat, huat....hehehe

drowning....pls. wake up.

@daijiao when is the announcement?

perseverance will prevail

Last few trading days, Solutn volume is much higher than topglov. Interest in the stock is still very high. Potential upside.

not moving much today ha!

Can still buy more?

When is the announcement, been waiting..